Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Associated Inferior Vena Cava Tumor Thrombus (NEOPAX)
Conditions: Renal Cancer; Kidney Cancer; Renal Cell Carcinoma; Inferior Vena Cava Thrombosis Interventions: Drug: Axitinib; Drug: Pembrolizumab Sponsors: University of Colorado, Denver; Cancer League of Colorado Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Neoadjuvant Therapy | Renal Cell Carcinoma | Research | Thrombosis | Urology & Nephrology